Specific articles on drug discovery operations, regulatory drafting, and the practical use of specialist AI expert agents in clinical-stage pipelines.
A working breakdown of how specialist AI expert agents, grounded in 21 CFR 1301 and historical precedent, can draft a submission-ready DEA application packet in two weeks instead of three months. What they are good for, and where counsel review is mandatory.
CultivationHow commercial mycology operators and clinical supply planners match a target alkaloid profile to a species and strain, with reference to the 2021 Psilocybin Cup record and the under-explored baeocystin-forward research opportunity.
More articles will be published as each platform capability ships. To be notified, email michael@crowelogic.com.
